Background

SciTech Development, a pioneering company in the biotechnology sector, specializes in innovative solutions that push the boundaries of scientific research and development. As they embarked on critical clinical trials for their groundbreaking therapies, SciTech partnered with Gadsly to manage their press releases, social media presence, and newsletters. The objective was to effectively communicate their progress, engage stakeholders, and build trust within the industry during this pivotal phase.

Challenges

SciTech Development faced several communication and outreach hurdles during their clinical trials:

• Limited Public Awareness: Despite their promising therapies, their advancements were not widely recognized.
• Fragmented Messaging: Communication channels lacked consistency and a cohesive brand voice.
• Audience Engagement: A strategic approach was needed to engage diverse stakeholders, including investors, researchers, regulatory bodies, and potential collaborators.

Gadsly’s Approach

Press Releases

Gadsly crafted professional press releases to announce SciTech’s milestones and clinical trial updates:

• Strategic Storytelling: Highlighted the significance and potential impact of the clinical trials.
• Broad Distribution: Leveraged media contacts and platforms to maximize reach among industry stakeholders.
• Timely Updates: Released announcements in sync with key trial phases to maintain momentum and interest.

Social Media Management

To build a strong social media presence, Gadsly implemented a strategy tailored to the clinical trial phase:

• Platform Optimization: Focused on LinkedIn and Twitter to reach professionals, industry leaders, and regulatory audiences.
• Content Creation: Developed posts featuring trial progress, key achievements, and industry insights.
• Engagement Tactics: Interacted with followers, shared updates, and participated in conversations about clinical research advancements.

Newsletters

Gadsly designed and distributed newsletters to keep SciTech’s audience informed throughout the trials:

• Audience Segmentation: Tailored newsletters for investors, partners, and industry professionals.
• Valuable Content: Included trial updates, research progress, upcoming events, and regulatory milestones.
• Call-to-Action (CTA): Encouraged readers to explore SciTech’s website, download resources, or contact the team for more information.

Results

Gadsly’s targeted communication strategy delivered measurable results for SciTech Development during their clinical trials:

Press Releases

• Increased Media Coverage: Secured features in prominent industry publications, boosting visibility of the clinical trials.
• Heightened Awareness: Broadened recognition of SciTech’s research and its potential impact on the industry.

Social Media Growth

• 50% Follower Growth: Expanded audience on LinkedIn and Twitter within six months.
• Enhanced Engagement: Trial-related posts generated significant interactions, including likes, shares, and comments.
• Expanded Reach: Gained visibility among key stakeholders, including investors and regulatory authorities.

Newsletter Success

• Higher Open Rates: Achieved an average open rate of 35%, surpassing industry benchmarks.
• Stronger Connections: Strengthened relationships with stakeholders by providing timely and valuable updates.

Conclusion

Gadsly’s support during SciTech Development’s clinical trials was instrumental in elevating their communication efforts. By delivering expertly crafted press releases, managing a dynamic social media presence, and distributing engaging newsletters, Gadsly helped SciTech maintain transparency, build trust, and solidify their leadership position in the biotechnology sector during a critical period.

Looking to amplify your company’s message during pivotal phases? Partner with Gadsly for strategic communication solutions!